Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors
This study will evaluate PTK787, a new oral drug that stops blood vessel development, in combination with Paclitaxel in patients with advanced solid tumors.
Neoplasm Metastasis|Carcinoma
DRUG: Paclitaxel plus PTK787
To evaluate the safety and tolerability of escalating doses of paclitaxel in combination with PTK787, Baseline through End of Study
To evaluate the pharmacokinetics of paclitaxel alone and in combination with PTK787 from patients with cancer accrued to this study, Baseline through End of Study
This study will evaluate PTK787, a new oral drug that stops blood vessel development, in combination with Paclitaxel in patients with advanced solid tumors.